Aptus Pharma Surge: From Local Player to National Powerhouse

Aptus Pharma Limited has shown remarkable financial growth, doubling its revenue and significantly increasing net profit. Established in 2010, the company operates an asset-light model with 250+ pharmaceutical formulations. It aims for a pan-India presence by 2030 and potentially entering the retail pharmacy chain sector.

New Delhi [India], April 29: Aptus Pharma Limited is experiencing a strong growth phase, evidenced by a doubling of its revenue and substantial net profit increase, emphasizing operational strength and scalability. The company's recent financial highlights reveal impressive revenue and profitability metrics.

Founded in 2010, Aptus Pharma has evolved rapidly, focusing on brand building, product range expansion, and robust market penetration. The company employs an asset-light model, partnering with WHO-GMP certified manufacturers to ensure quality production. It boasts a diverse product line with over 250 formulations.

Aiming for nationwide presence by 2030, the company is strengthening its distribution network and may enter the retail pharmacy chain sector. Listed on the BSE SME platform, Aptus is poised to become a significant national pharmaceutical player.